Erik A M Jansen
Overview
Explore the profile of Erik A M Jansen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hinic S, van der Post R, Vreede L, Schuurs-Hoeijmakers J, Koene S, Jansen E, et al.
JNCI Cancer Spectr
. 2024 Jun;
8(4).
PMID: 38848470
CHEK2 is considered to be involved in homologous recombination repair (HRR). Individuals who have germline pathogenic variants (gPVs) in CHEK2 are at increased risk to develop breast cancer and likely...
2.
de Bitter T, de Reuver P, de Savornin Lohman E, Kroeze L, Vink-Borger M, van Vliet S, et al.
NPJ Precis Oncol
. 2022 Nov;
6(1):83.
PMID: 36335173
Gallbladder cancer (GBC) is a rare, highly aggressive malignancy with a 5-year survival rate of 5-10% in advanced cases, highlighting the need for more effective therapies. The aim of this...
3.
Lassche G, van Helvert S, Eijkelenboom A, Tjan M, Jansen E, Van Cleef P, et al.
Cancers (Basel)
. 2022 Sep;
14(17).
PMID: 36077692
Salivary gland cancer (SGC) is a rare cancer for which systemic treatment options are limited. Therefore, it is important to characterize its genetic landscape in search for actionable aberrations, such...
4.
Hofste L, Geerlings M, Kamping E, Kouwenhoven N, von Rhein D, Jansen E, et al.
Dis Colon Rectum
. 2022 Jul;
66(6):796-804.
PMID: 35857852
Background: Accurate biomarkers to monitor tumor load and response in metastatic colorectal cancer patients undergoing surgery could optimize treatment regimens. Objective: This study aimed to explore the clinical validity of...
5.
Palles C, West H, Chew E, Galavotti S, Flensburg C, Grolleman J, et al.
Am J Hum Genet
. 2022 Apr;
109(5):953-960.
PMID: 35460607
We report an autosomal recessive, multi-organ tumor predisposition syndrome, caused by bi-allelic loss-of-function germline variants in the base excision repair (BER) gene MBD4. We identified five individuals with bi-allelic MBD4...
6.
van den Heuvel G, Kroeze L, Ligtenberg M, Grunberg K, Jansen E, von Rhein D, et al.
Respir Res
. 2021 Nov;
22(1):302.
PMID: 34819052
Background: Lung cancer is the leading cause of cancer death worldwide. With the growing number of targeted therapies and the introduction of immuno-oncology (IO), personalized medicine has become standard of...
7.
de Bitter T, Kroeze L, de Reuver P, van Vliet S, Vink-Borger E, von Rhein D, et al.
JCO Precis Oncol
. 2021 May;
5.
PMID: 34036234
Purpose: Neuroendocrine carcinomas and mixed neuroendocrine non-neuroendocrine neoplasms of the gallbladder (NE GBC) are rare and highly aggressive entities. The cell of origin of NE GBC has been a matter...
8.
Steeghs E, Kroeze L, Tops B, van Kempen L, Ter Elst A, Kastner-van Raaij A, et al.
BMC Cancer
. 2020 Apr;
20(1):291.
PMID: 32264863
Background: Sensitive and reliable molecular diagnostics is needed to guide therapeutic decisions for cancer patients. Although less material becomes available for testing, genetic markers are rapidly expanding. Simultaneous detection of...
9.
Kroeze L, de Voer R, Kamping E, von Rhein D, Jansen E, Hermsen M, et al.
J Mol Diagn
. 2020 Mar;
22(6):757-769.
PMID: 32205293
Stratification of patients for targeted and immune-based therapies requires extensive genomic profiling that enables sensitive detection of clinically relevant variants and interrogation of biomarkers, such as tumor mutational burden (TMB)...
10.
Grolleman J, de Voer R, Elsayed F, Nielsen M, Weren R, Palles C, et al.
Cancer Cell
. 2019 Feb;
35(2):256-266.e5.
PMID: 30753826
Biallelic germline mutations affecting NTHL1 predispose carriers to adenomatous polyposis and colorectal cancer, but the complete phenotype is unknown. We describe 29 individuals carrying biallelic germline NTHL1 mutations from 17...